Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

Tolaney, Sara M.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Grischke, Eva-Maria; Llombart-Cussac, Antonio; Soliman, Hatem; Wang, Hong; Wijayawardana, Sameera; Jansen, Valerie M.; Litchfield, Lacey M.; Sledge, George W., Jr.

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2022-12-20T09:06:28Z
dc.date.available	2022-12-20T09:06:28Z
dc.date.issued	2022
dc.identifier.issn	1078-0432
dc.identifier.uri	http://hdl.handle.net/10900/134444
dc.language.iso	en	de_DE
dc.publisher	Amer Assoc Cancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.1158/1078-0432.CCR-21-3276	de_DE
dc.subject.ddc	610	de_DE
dc.title	Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_01168
utue.publikation.seiten	1500-1506	de_DE
utue.personen.roh	Tolaney, Sara M.
utue.personen.roh	Toi, Masakazu
utue.personen.roh	Neven, Patrick
utue.personen.roh	Sohn, Joohyuk
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Llombart-Cussac, Antonio
utue.personen.roh	Soliman, Hatem
utue.personen.roh	Wang, Hong
utue.personen.roh	Wijayawardana, Sameera
utue.personen.roh	Jansen, Valerie M.
utue.personen.roh	Litchfield, Lacey M.
utue.personen.roh	Sledge, George W., Jr.
dcterms.isPartOf.ZSTitelID	Clinical Cancer Research	de_DE
dcterms.isPartOf.ZS-Issue	8	de_DE
dcterms.isPartOf.ZS-Volume	28	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE